ISG Technologies is reorganizing its senior management team after the departure of president and COO Max Rutherford, who is leaving the firm to pursue other opportunities. The Mississauga, Ontario-based PACS and image-guided surgery firm has formed two
ISG Technologies is reorganizing its senior management team after the departure of president and COO Max Rutherford, who is leaving the firm to pursue other opportunities. The Mississauga, Ontario-based PACS and image-guided surgery firm has formed two new general manager positions that will handle product groups and largely take over the COO responsibilities exercised by Rutherford, according to ISG. The company has also created a senior vice president of sales position that will be responsible for building customer relationships.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.